Abstract
Clostridium difficile is a gram-positive, spore-forming, toxin-producing anaerobic bacillus that is being increasingly implicated as the leading cause of diarrhea and colitis, particularly in hospitalized, elderly patients. Studies to date suggest that C. difficile toxins A and B play a major role in the observed colonic inflammation and associated disease pathogenesis; however, the role of other potential bacterial factors at present remains unknown. Early effects of C. difficile on host intestinal epithelia include modest induction of innate immune responses with progressive loss of intestinal epithelial cell barrier function and cell death.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cloud J and Kelly CP. (2007) Update on Clostridium difficile associated disease. Curr Opin Gastroenterol 23(1), 4–9.
Issa M, Ananthakrishnan AN and Binion DG. (2008) Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis 14(10), 1432–1442.
Bajaj-Elliott M and Sanderson IR 2008. Nutrition and gene expression, pp. 209–222 in Nutrition in Pediatrics, 4th ed., BC Decker Inc, Hamilton, Ontario.
Pastorelli L, Vecchi M, Cominelli F and Pizarro T. (2008) Genetic regulation of epithelial barrier function: recent insights into the pathogenesis of inflammatory bowel disease. Inflamm Bowel Dis Monit 8(4), 124–133.
Sutton PA, et al. (2008) Essential role of toxin A in C. difficile 027 and reference strain supernatant-mediated disruption of Caco-2 intestinal epithelial barrier function. Clin Exp Immunol 153(3), 439–447.
Johal SS, et al. (2004) Differential effects of varying concentrations of Clostridium difficile toxin A on epithelial barrier function and expression of cytokines. J Infect Dis 189(11), 2110–2119.
Mahida YR, et al. (1996) Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment. Gut 38(3), 337–347.
Viswanathan VK, et al. (2004) Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function. Infect Immun 72(6), 3218–3227.
Canny G, et al. (2006) Toxigenic C. difficile induced inflammatory marker expression by human intestinal epithelial cells is asymmetrical. Life Sci 78(9), 920–925.
Viswanathan VK, et al. (2008) Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis. Am J Physiol Gastrointest Liver Physiol 294(5), G1165–G1170.
Tirumalasetty PP and Eley JG. (2006) Permeability enhancing effects of the alkylglycoside, octylglucoside, on insulin permeation across epithelial membrane in vitro. J Pharm Sci 9(1), 32–39.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Jafari, N.V., Allan, E., Bajaj-Elliott, M. (2010). Human Intestinal Epithelial Response(s) to Clostridium difficile . In: Mullany, P., Roberts, A.P. (eds) Clostridium difficile. Methods in Molecular Biology™, vol 646. Humana Press. https://doi.org/10.1007/978-1-60327-365-7_9
Download citation
DOI: https://doi.org/10.1007/978-1-60327-365-7_9
Publisher Name: Humana Press
Print ISBN: 978-1-60327-364-0
Online ISBN: 978-1-60327-365-7
eBook Packages: Springer Protocols